Related Experiment Video
Updated: Oct 3, 2025

Isolation and Characterization of Single Cells from Zebrafish Embryos
Published on: March 12, 2016
Ruvbl2 Suppresses Cardiomyocyte Proliferation During Zebrafish Heart Development and Regeneration
Michka Sharpe1,2,3, Juan Manuel González-Rosa1,2,3, Felicia Wranitz1,3
1Division of Basic and Translational Cardiovascular Research, Department of Cardiology, Boston Children's Hospital, Boston, MA, United States.
Abstract:
Cardiomyocyte proliferation is an important source of new myocardium during heart development and regeneration. Consequently, mutations in drivers of cardiomyocyte proliferation cause congenital heart disease, and infarcted human hearts scar because cardiomyocytes exit the cell cycle postnatally. To boost cardiomyocyte proliferation in either setting, critical regulators must be identified. Through an ENU screen in zebrafish, the liebeskummer (lik) mutant was isolated and described as having elevated cardiomyocyte numbers during embryogenesis. The lik mutation results in a three amino acid insertion into Ruvbl2, a highly conserved ATPase. Because both gain- and loss-of-function properties have been described for ruvbl2 , it remains unclear whether Ruvbl2 positively or negatively regulates cardiomyocyte proliferation. Here, we demonstrate that Ruvbl2 is a suppressor of cardiomyocyte proliferation during zebrafish heart development and regeneration. First, we confirmed speculation that augmented cardiomyocyte numbers in ruvbl2 hearts arise by hyperproliferation. To characterize bona fide ruvbl2 null animals, we created a ruvbl2 locus deletion allele (ruvbl2 ). Like ruvbl2 mutants, ruvbl2 Δ/Δ and compound heterozygote ruvbl2 animals display ventricular hyperplasia, demonstrating that lik is a loss of function allele and that ruvbl2 represses cardiomyocyte proliferation. This activity is autonomous because constitutive myocardial overexpression of Ruvbl2 is sufficient to suppress cardiomyocyte proliferation in control hearts and rescue the hyperproliferation observed in ruvbl2 Δ/Δ mutant hearts. Lastly, heat-shock inducible overexpression of Ruvbl2 suppresses cardiomyocyte proliferation during heart regeneration and leads to scarring. Together, our data demonstrate that Ruvbl2 functions autonomously as a suppressor of cardiomyocyte proliferation during both zebrafish heart development and adult heart regeneration.
Insights
Ruvbl2 suppresses cardiomyocyte proliferation during zebrafish heart development and regeneration. Loss of Ruvbl2 function leads to increased cardiomyocyte numbers, while its overexpression causes scarring, highlighting its role in heart repair.
Area of Science:
- Cardiovascular Biology
- Developmental Biology
- Regenerative Medicine
Background:
- Cardiomyocyte proliferation is crucial for heart development and regeneration.
- Dysregulation of cardiomyocyte proliferation contributes to congenital heart disease and post-infarction scarring.
- Identifying regulators of cardiomyocyte proliferation is key for therapeutic interventions.
Purpose of the Study:
- To investigate the role of Ruvbl2 in regulating cardiomyocyte proliferation during zebrafish heart development and regeneration.
- To determine whether Ruvbl2 acts as a positive or negative regulator of cardiomyocyte proliferation.
Main Methods:
- Utilized zebrafish ENU screening to identify the 'liebeskummer' (lik) mutant with elevated cardiomyocyte numbers.
- Created a Ruvbl2 locus deletion allele (ruvbl2Δ/Δ) to characterize null animals.
- Performed constitutive and heat-shock inducible overexpression studies of Ruvbl2 in myocardial cells.
Main Results:
- The 'liebeskummer' mutation is a loss-of-function allele of Ruvbl2, causing ventricular hyperplasia due to hyperproliferation.
- Ruvbl2 functions autonomously to repress cardiomyocyte proliferation during development and regeneration.
- Overexpression of Ruvbl2 suppresses proliferation and exacerbates scarring during heart regeneration.
Conclusions:
- Ruvbl2 acts as a critical suppressor of cardiomyocyte proliferation in zebrafish.
- Targeting Ruvbl2 may offer therapeutic potential for promoting heart regeneration and preventing congenital heart defects.

